626 related articles for article (PubMed ID: 17593028)
1. Biphenotypic acute leukaemia: a case series.
Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
[TBL] [Abstract][Full Text] [Related]
2. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
4. [Study on the clinical characteristics of biphenotypic acute leukemia].
Mi Y; Bian S; Meng Q; Xue Y; Yu M; Chen G; Li D; Chen Y; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):352-4. PubMed ID: 11877003
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
[TBL] [Abstract][Full Text] [Related]
6. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Büyükçelik A; Yalçin B; Utkan G; Doruk H
Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
[No Abstract] [Full Text] [Related]
7. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
8. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
9. [Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)].
Bruntsch U; Osieka R; GAllmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1975 Nov; 100(48):2478-82. PubMed ID: 1059536
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
Lu Y; Jin J; Chen ZM; Lou JY; Xu WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):596-9. PubMed ID: 15583990
[TBL] [Abstract][Full Text] [Related]
11. Outcome of treatment with Hyper-CVAD regimen in Chinese patients with acute lymphocytic leukemia.
Xu W; Li JY; Qian SX; Wu HX; Lu H; Chen LJ; Zhang SJ; Lu RL; Sheng RL
Leuk Res; 2008 Jun; 32(6):930-5. PubMed ID: 18061665
[TBL] [Abstract][Full Text] [Related]
12. [Study on the clinical characteristics of adult biphenotypic acute leukaemia].
Zhang J; Mi YC; Wang Y; Lin D; Li W; Sun XM; Zhou K; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):18-21. PubMed ID: 19563029
[TBL] [Abstract][Full Text] [Related]
13. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
[TBL] [Abstract][Full Text] [Related]
14. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
15. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
17. [Current status of complete remission rate of acute leukemia in Shanghai].
Shanghai Leukemia Cooperative Group Shanghai 200040 China
Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].
Li QH; DU X; Huang ZL; Luo CW; Zhong LY; Lin W
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1195-7. PubMed ID: 16029595
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute leukemia].
Barry A; Delage JM
Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
[No Abstract] [Full Text] [Related]
20. Granular acute lymphoblastic leukemia: a case report and literature review.
Pitman SD; Huang Q
Am J Hematol; 2007 Sep; 82(9):834-7. PubMed ID: 17546641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]